Krems an der Donau, Austria, 1 September 2017 – OrthoSera GmbH, an orthobiologics company developing serum-based therapeutic solutions in orthopedics and the dental sector is pleased to announce the appointment of Dr. Tamás Miklós Polónyi, to the position of Managing Director besides co-founder and CEO Dr. Zsombor Lacza. Tamás is replacing Björn Ehring , the founding CFO of the company.
In addition to his degree in economics, Tamás is a registered accountant and lawyer with a 20-year career in the finance field. He began his professional career at the Hungarian subsidiary of leading Italian bank Intesa Sanpaolo. After subsequently heading the Hungarian corporate banking business within Banco Popolare group he joined market-leading OTP Bank in 2011 as Head of Department in the Large Corporate and Project Finance Division. Tamás joined OrthoSera GmbH from Crnagorska Komercijalna Banka, the Montenegrin subsidiary of OTP Group. Within the management team, he is taking over the Finance, Accounting, and Legal responsibilities and is also playing an active role in OrthoSera’s business development activities.
OrthoSera’s management and investors would like to thank Björn Ehring for his invaluable contribution to the company’s establishment an transformation into a commercial-stage provider of blood serum-based regenerative therapies including the successful closing of several financing rounds. Björn is joining OrthoSera’s Business Advisory Board in order to further support management with strategic advice.